MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from share
issuance
$6,955K
Net cash provided by
financing activities
$4,710K
Canceled cashflow
$2,245K
Net increase in cash
and cash...
$2,237K
Canceled cashflow
$2,474K
Share repurchase
$1,138K
Share issuance costs
$823K
Warrant issuance costs
$284K
Stock-based compensation
expense
$1,469K
Trade and other
payables
$458K
Depreciation and
amortization
$65K
Prepaid expenses and
other current assets
-$26K
Net cash used in
operating activities
-$2,456K
Net cash used in
investing activities
-$18K
Canceled cashflow
$2,018K
Net loss
-$3,883K
Investment of joint venture
$13K
Purchase of property,
plant and equipment
$5K
Change in fair value of
warrant liabilities
-$380K
R&d tax incentive
$186K
Unrealized loss on foreign
currency remeasurement
$25K
Back
Back
Cash Flow
Incannex Healthcare Inc. (IXHL)
Incannex Healthcare Inc. (IXHL)
source: myfinsight.com